PoliticalRepoPoliticalRepo

United States · Bill · S

S. 2164 (117th)

Lower Costs, More Cures Act of 2021

referredUnited States· United States Congress· EN

Introduced

22 June 2021

Last action

22 June 2021 · Introduced

Status

Read twice and referred to the Committee on Finance.

Sponsors

Mike Crapo, Sen. Burr, Richard [R-NC], Tim Scott, Steve Daines, James Risch, Joni Ernst, Roger Marshall, Thomas Tillis, John Hoeven

Subjects

Healthcare

Source updated

3 January 2025

Healthcare

Summary

Lower Costs, More Cures Act of 2021 This bill establishes and modifies several programs and requirements to address prescription drug prices, particularly in relation to Medicare and Medicaid. Among other changes, the bill requires the Centers for Medicare & Medicaid Services to publish certain information, as reported by pharmacy benefit managers (PBMs), relating to generic dispensing rates, drug discounts and rebates, and payments between PBMs, health plans, and pharmacies; caps annual out-of-pocket spending under the Medicare prescription drug benefit; allows prescription drug plan sponsors under the Medicare prescription drug benefit to offer additional plans in a region; establishes requirements under the Medicaid Drug Rebate Program for certain gene therapies for which prices are indexed to achieved outcomes; and establishes the position of Chief Pharmaceutical Negotiator in the Office of the U.S. Trade Representative.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 22 June 2021

    Introduced

    Read twice and referred to the Committee on Finance.

    Source: IntroReferral

  2. 22 June 2021

    Introduced

    Introduced in Senate

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in Senate (text)

View fileDownload file

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.